MMHP
MRK icon

Murphy Middleton Hinkle & Parker’s Merck MRK Stock Holding History

Murphy Middleton Hinkle & Parker’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
10,472
+9
+0.1% +$1.05K 0.55% 54
2026
Q1 		$1.26M Buy
10,463
+6,346
+154% +$733K 0.58% 50
2025
Q4 		$303K Sell
4,117
-6,364
-61% -$597K 0.15% 113
2025
Q3 		$880K Buy
10,481
+26
+0.2% +$2.14K 0.43% 67
2025
Q2 		$938K Hold
10,455
– – 0.53% 58
2025
Q1 		$938K Buy
10,455
+9
+0.1% +$840 0.53% 58
2024
Q4 		$1.04M Sell
10,446
-355
-3% -$36.6K 0.59% 54
2024
Q3 		$1.23M Sell
10,801
-339
-3% -$40.3K 0.66% 44
2024
Q2 		$1.38M Sell
11,140
-142
-1% -$18.3K 0.8% 36
2024
Q1 		$1.49M Sell
11,282
-1
-0% -$123 0.87% 35
2023
Q4 		$1.23M Sell
11,283
-259
-2% -$26.9K 0.76% 39
2023
Q3 		$1.19M Sell
11,542
-42
-0.4% -$4.53K 0.76% 42
2023
Q2 		$1.34M Sell
11,584
-40
-0.3% -$4.54K 0.84% 40
2023
Q1 		$1.24M Sell
11,624
-184
-2% -$19.9K 0.77% 43
2022
Q4 		$1.31M Buy
11,808
+9
+0.1% +$920 0.82% 42
2022
Q3 		$1.02M Buy
11,799
+10
+0.1% +$893 0.71% 45
2022
Q2 		$1.07M Sell
11,789
-40
-0.3% -$3.55K 0.7% 47
2022
Q1 		$971K Sell
11,829
-39
-0.3% -$3.08K 0.52% 56
2021
Q4 		$910K Buy
11,868
+11
+0.1% +$876 0.48% 66
2021
Q3 		$891K Sell
11,857
-328
-3% -$24.9K 0.52% 62
2021
Q2 		$948K Sell
12,185
-615
-5% -$45.7K 0.53% 61
2021
Q1 		$942K Buy
12,800
+24
+0.2% +$1.77K 0.55% 59
2020
Q4 		$997K Sell
12,776
-245
-2% -$18.7K 0.66% 50
2020
Q3 		$1.03M Sell
13,021
-470
-3% -$36.8K 0.75% 49
2020
Q2 		$996K Buy
13,491
+15
+0.1% +$1.13K 0.73% 50
2020
Q1 		$989K Sell
13,476
-1,039
-7% -$81.7K 0.87% 45
2019
Q4 		$1.26M Buy
14,515
+9
+0.1% +$739 0.84% 46
2019
Q3 		$1.17M Sell
14,506
-32
-0.2% -$2.56K 0.83% 44
2019
Q2 		$1.16M Sell
14,538
-1,157
-7% -$88.6K 0.83% 45
2019
Q1 		$1.25M Sell
15,695
-511
-3% -$38.2K 0.86% 42
2018
Q4 		$1.18M Sell
16,206
-786
-5% -$55.5K 0.9% 38
2018
Q3 		$1.15M Buy
16,992
+120
+0.7% +$7.64K 0.81% 45
2018
Q2 		$977K Buy
16,872
+228
+1% +$12.9K 0.73% 47
2018
Q1 		$865K Buy
16,644
+104
+0.6% +$5.62K 0.67% 54
2017
Q4 		$888K Buy
+16,540
New +$917K 0.66% 53

Other funds holding MRK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Murphy Middleton Hinkle & Parker's MRK Position: Q2 2026 in Review

Murphy Middleton Hinkle & Parker increased its Merck (MRK) stake by 0.09% in Q2 2026, buying an estimated $1.05K and bringing the position to 10,472 shares worth $1.35M. The position accounts for 0.55% of the portfolio, ranked #54.

Murphy Middleton Hinkle & Parker first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.49M in Q1 2024. 810 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Murphy Middleton Hinkle & Parker held 10,472 shares of Merck worth $1.35M as of Q2 2026.
  • Murphy Middleton Hinkle & Parker bought 9 Merck shares in Q2 2026, an estimated $1.05K.
  • Merck made up 0.55% of Murphy Middleton Hinkle & Parker's portfolio in Q2 2026, its #54 holding.
  • Murphy Middleton Hinkle & Parker first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
  • Murphy Middleton Hinkle & Parker's Merck position peaked at $1.49M in Q1 2024.
  • 810 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Murphy Middleton Hinkle & Parker's 13F filing for Q2 2026, filed 14 Jul 2026.